News
Bioibericas Heparin Science has been invited as a speaker to the 5th Workshop on characterization of heparin products taking place on August 14th and 15th in the USP Headquarters located in Rockville, Maryland, USA.
It is a phase IV clinical trial currently being carried out in 38 medical centers in Spain, Germany, France and Poland. The objective of the MOVES (Multicenter Osteoarthritis InterVEntion trial with Sysadoas) it is to prove that combining chondroitin sulfate and glucosamine sulfate is as efficient as celecoxib for the treatment of moderate to severe pain in knee osteoarthritis.
Bioberica presents Goodogs®, a new range of treat snacks for dogs that brings something new and different to the world of pet snacks. Here at Bioiberica we believe that snacks can be much more digestible, tasty and fun. As always, we use fresh, top quality ingredients.
The Bioibérica team and the staff of its Brazilian representative, Agro Commercial Wiser, performed technical support and information tasks at the fair.
Heparin Science Business Unit is glad to inform that our crude heparin facility in Italy passed satisfactorily a United States Food and Drug Administration (US FDA) Inspection for compliance with US FDA requirements.